Regulation of the expression of claudin 23 by the enhancer of zeste 2 polycomb group protein in colorectal cancer

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 728-736

  Maryan, Natalia ^a   Statkiewicz, Malgorzata ^a   Mikula, Michal ^a   Goryca, Krzysztof ^a   Paziewska, Agnieszka ^a   Strzałkowska, Adriana ^a   Dabrowska, Michalina ^a   Bujko, Mateusz ^a   Ostrowski, Jerzy ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

ChIP Seq; Claudin 23; Colorectal cancer; Enhancer of zeste 2; GSK126

Indexed keywords

BETA ACTIN; CLAUDIN; CLAUDIN 23; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GSK 126; HEMOGLOBIN BETA CHAIN; HISTONE H3; LYSINE; MESSENGER RNA; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; CLDN23 PROTEIN, HUMAN; EZH2 PROTEIN, HUMAN; GSK126; INDOLE DERIVATIVE; POLYCOMB REPRESSIVE COMPLEX 2; PYRIDONE DERIVATIVE;

ARTICLE; CELL ADHESION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENE SILENCING; HCT116 CELL LINE; HISTONE METHYLATION; HISTONE MODIFICATION; HT 29 CELL LINE; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; COLORECTAL TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CLAUDINS; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDOLES; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; PYRIDONES;

EID: 84926615843     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3378     Document Type: Article

References (36)

1. Di Croce L and Helin K: Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol 20: 1147-1155, 2013.
2. Chang CJ and Hung MC: The role of EZH2 in tumour progression. Br J Cancer 106: 243-247, 2012.
3. Forbes MS: Cell Structure. In: Cell Physiology Source Book (4th edition). Sperelakis N (ed) Academic Press, San Diego, CA, pp67-83, 2012.
4. Ding L, Lu Z, Lu Q and Chen YH: The claudin family of proteins in human malignancy: a clinical perspective. Cancer Manag Res 5: 367-375, 2013.
5. Findley MK and Koval M: Regulation and roles for claudin family tight junction proteins. IUBMB Life 61: 431-437, 2009.
6. Günzel D and Yu ASL: Claudins and the modulation of tight junction permeability. Physiol Rev 93: 525-569, 2013.
7. Turksen K and Troy TC: Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 1816: 73-79, 2011.
8. Valle BL and Morin PJ: Claudins in Cancer Biology. In: Current Topics in Membranes. Yu ASL (ed.) Vol 65. Academic Press, Amsterdam, pp293-333, 2010.
9. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
10. Frixen UH, Behrens J, Sachs M, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
11. Hirohashi S and Kanai Y: Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581, 2003.
12. Skrzypczak M, Goryca K, Rubel T, et al: Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 5: e13091, 2010.
13. Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M and Ostrowski J: Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11: 215-224, 2011.
14. Flanagin S, Nelson JD, Castner DG, Denisenko O and Bomsztyk K: Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events. Nucleic Acids Res 36: e17, 2008.
15. Yu J, Feng Q, Ruan Y, Komers R, Kiviat N and Bomsztyk K: Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assays. BMC Mol Biol 12: 49, 2011.
16. Mikula M, Bomsztyk K, Goryca K, Chojnowski K and Ostrowski J: Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3′-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease. J Biol Chem 288: 24788-24798, 2013.
17. Aird D, Ross MG, Chen W-S, et al: Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol 12: R18, 2011.
18. Langmead B, Trapnell C, Pop M and Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25, 2009.
19. Zhang Y, Liu T, Meyer CA, et al: Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137, 2008.
20. Kent WJ, Sugnet CW, Furey TS, et al: The human genome browser at UCSC. Genome Res 12: 996-1006, 2002.
21. ENCODE Project Consortium: An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74, 2012.
22. McCabe MT, Ott HM, Ganji G, et al: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492: 108-112, 2012.
23. Mikula M, Gaj P, Dzwonek K, et al: Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter. DNA Res 17: 245-260, 2010.
24. Singh AB, Sharma A and Dhawan P: Claudin family of proteins and cancer: an overview. J Oncol 2010: 2010.
25. Chi P, Allis CD and Wang GG: Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10: 457-469, 2010.
26. Bernstein BE, Mikkelsen TS, Xie X, et al: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326, 2006.
27. Larson JL and Yuan GC: Chromatin states accurately classify cell differentiation stages. PLoS One 7: e31414, 2012.
28. Rodriguez J, Muñoz M, Vives L, Frangou CG, Groudine M and Peinado MA: Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci USA 105: 19809-19814, 2008.
29. Voigt P, Tee WW and Reinberg D: A double take on bivalent promoters. Genes Dev 27: 1318-1338, 2013.
30. Mikkelsen TS, Ku M, Jaffe DB, et al: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560, 2007.
31. Ku M, Koche RP, Rheinbay E, et al: Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 4: e1000242, 2008.
32. Brookes E, de Santiago I, Hebenstreit D, et al: Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell 10: 157-170, 2012.
33. Kwon MJ, Kim SH, Jeong HM, et al: Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. Lab Invest 91: 1652-1667, 2011.
34. Kwon MJ, Kim SS, Choi YL, et al: Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis 31: 974-983, 2010.
35. Katoh M and Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689, 2003.
36. Pitule P, Vycital O, Bruha J, et al: Differential expression and prognostic role of selected genes in colorectal cancer patients. Anticancer Res 33: 4855-4865, 2013.